troglitazone has been researched along with dihydrotestosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciletti, N; Deplewski, D; Kentsis, A; Rosenfield, RL | 1 |
| Carey, M; Hisatake, JI; Holden, S; Ikezoe, T; Koeffler, HP; Tomoyasu, S | 1 |
2 other study(ies) available for troglitazone and dihydrotestosterone
| Article | Year |
|---|---|
Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors.
Topics: Animals; Antioxidants; Base Sequence; Cell Differentiation; Chromans; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Synergism; Epithelial Cells; Gene Expression; Male; Molecular Sequence Data; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Sebum; Sequence Homology, Nucleic Acid; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 1999 |
Down-Regulation of prostate-specific antigen expression by ligands for peroxisome proliferator-activated receptor gamma in human prostate cancer.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Agents; Blotting, Western; Chromans; Dihydrotestosterone; Down-Regulation; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Ligands; Male; Middle Aged; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Cytoplasmic and Nuclear; Response Elements; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Troglitazone | 2000 |